Skip to main content
CAI logo
CAI
(NASDAQ)
Caris Life Sciences, Inc.
$28.01-- (--)
Loading... - Market loading

Caris Life Sciences (CAI) Stock Price & Financial Analysis

Caris Life Sciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$25.77 - $28.32
52-Week High$39.30
52-Week Low$14.19
Open$26.19
Volume6.82M
Average Volume (3M)4.92M
Market Cap7.91B
Shares Outstanding282.56M
P/E Ratio (TTM)232.90
Price to Sales (P/S)8.72
Price to Book (P/B)2.52
EV/EBITDA71.54
Revenue (TTM)907.29M
Net Income (TTM)33.98M
Free Cash Flow (TTM)123.46M
EPS (TTM)$0.06
Profit Margin3.75%
Operating Margin11.94%
Return on Equity (ROE)1.08%
Debt to Equity0.12
50-Day MA$18.78
200-Day MA$20.91
52-Week Change-27.21%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateJun 9, 2021

Frequently Asked Questions About Caris Life Sciences

What is the current stock price for CAI?

As of the latest trading session, CAI stock trades at $28.01. The 52-week range is $14.19–$39.30, with a day range of $25.77–$28.32.

What is the P/E ratio for CAI?

Caris Life Sciences's trailing P/E ratio is 232.9, meaning investors pay $232.9 for every $1 of annual earnings. Caris Life Sciences operates in the Healthcare sector.

Does CAI pay dividends?

Caris Life Sciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CAI?

Based on 6 analysts, the consensus for CAI is Buy.

What is the market cap of CAI?

Caris Life Sciences's market capitalization is $7.91B, classifying it as a mid-cap company. Caris Life Sciences operates in the Healthcare sector within the Biotechnology industry.